http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 01 Jun 2026 06:07:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++BIODESIX+INC+++++++++++++++++++++++++/26578470.html si-local-file:///var/storage/secattach/20260601/26578470.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++BIODESIX+INC+++++++++++++++++++++++++/26578470.html Mon, 01 Jun 2026 06:07:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++BIODESIX+INC+++++++++++++++++++++++++/26578470.html si-local-file:///var/storage/secattach/20260601/26578470.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++BIODESIX+INC+++++++++++++++++++++++++/26578470.html Mon, 01 Jun 2026 06:07:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++BIODESIX+INC+++++++++++++++++++++++++/26578187.html si-local-file:///var/storage/secattach/20260601/26578187.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++BIODESIX+INC+++++++++++++++++++++++++/26578187.html Mon, 01 Jun 2026 06:00:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++BIODESIX+INC+++++++++++++++++++++++++/26578187.html si-local-file:///var/storage/secattach/20260601/26578187.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++BIODESIX+INC+++++++++++++++++++++++++/26578187.html Mon, 01 Jun 2026 06:00:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++BIODESIX+INC+++++++++++++++++++++++++/26536134.html si-local-file:///var/storage/secattach/20260521/26536134.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++BIODESIX+INC+++++++++++++++++++++++++/26536134.html Thu, 21 May 2026 16:39:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++BIODESIX+INC+++++++++++++++++++++++++/26536134.html si-local-file:///var/storage/secattach/20260521/26536134.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++BIODESIX+INC+++++++++++++++++++++++++/26536134.html Thu, 21 May 2026 16:39:00 -0400 BDSX O.04749349 http://www.streetinsider.com/Press+Releases/Biodesix+to+Participate+in+Upcoming+Investor+Conferences/26530670.html <p>LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participate in three upcoming investor conferences:</p> <p><strong>Craig-Hallum 23</strong>^{<strong>rd</strong>}<strong> Annual Institutional Investor Conference</strong><br />1x1 meetings only <br />Date: Thursday, May 28, 2026<br />Location: Minneapolis, MN</p> <p><strong>William Blair 46</strong>^{<strong>th</strong>}<strong> Annual Growth Stock Conference</strong><br />Presentation and 1x1 meetings <br />Presentation Date and Time: Wednesday, June 3, 2026 at 2:00 PM CT<br />Location: Chicago, IL</p> <p><strong>TD Cowen Annual Tools/Dx Revolution </strong><br />1x1 meetings only<br />Date: Wednesday, June 24, 2026<br />Location: Dana Point, http://www.streetinsider.com/Press+Releases/Biodesix+to+Participate+in+Upcoming+Investor+Conferences/26530670.html Thu, 21 May 2026 06:00:00 -0400 BDSX http://www.streetinsider.com/Globe+Newswire/Biodesix+to+Participate+in+Upcoming+Investor+Conferences/26530670.html <p>LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participate in three upcoming investor conferences:</p> <p><strong>Craig-Hallum 23</strong>^{<strong>rd</strong>}<strong> Annual Institutional Investor Conference</strong><br />1x1 meetings only <br />Date: Thursday, May 28, 2026<br />Location: Minneapolis, MN</p> <p><strong>William Blair 46</strong>^{<strong>th</strong>}<strong> Annual Growth Stock Conference</strong><br />Presentation and 1x1 meetings <br />Presentation Date and Time: Wednesday, June 3, 2026 at 2:00 PM CT<br />Location: Chicago, IL</p> <p><strong>TD Cowen Annual Tools/Dx Revolution </strong><br />1x1 meetings only<br />Date: Wednesday, June 24, 2026<br />Location: Dana Point, http://www.streetinsider.com/Globe+Newswire/Biodesix+to+Participate+in+Upcoming+Investor+Conferences/26530670.html Thu, 21 May 2026 06:00:00 -0400 BDSX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIODESIX+INC++++++++++++++For%3A+May+19/26528651.html si-local-file:///var/storage/secattach/20260520/26528651.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIODESIX+INC++++++++++++++For%3A+May+19/26528651.html Wed, 20 May 2026 16:19:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIODESIX+INC++++++++++++++For%3A+May+19/26528651.html si-local-file:///var/storage/secattach/20260520/26528651.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIODESIX+INC++++++++++++++For%3A+May+19/26528651.html Wed, 20 May 2026 16:19:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++BIODESIX+INC+++++++++++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504580.html si-local-file:///var/storage/secattach/20260515/26504580.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++BIODESIX+INC+++++++++++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504580.html Fri, 15 May 2026 16:00:00 -0400 BDSX O.04749349 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++BIODESIX+INC+++++++++++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504580.html si-local-file:///var/storage/secattach/20260515/26504580.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++BIODESIX+INC+++++++++++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/26504580.html Fri, 15 May 2026 16:00:00 -0400 BDSX O.04749349 http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Press+Releases/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html <p align="left">LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify Lung® testing will be shared at the American Thoracic Society (ATS) Annual Meeting, May 15 – 20, 2026 | Orlando, FL. The presentations further reinforce the accelerating adoption of Biodesix blood-based testing for earlier detection of lung cancer.</p> <p align="left">“The presentations at ATS highlight the real-world clinical value and economic advantages of lung nodule management programs that use Nodify Lung® testing for risk stratification,” said Scott Hutton, http://www.streetinsider.com/Globe+Newswire/Biodesix+Announces+ATS+2026+Presentations+Providing+Real-World+Clinical+Evidence+and+Healthcare+System+Economic+Value+for+Nodify+Lung%C2%AE+Testing+Strategy/26466286.html Mon, 11 May 2026 09:17:00 -0400 A.19718279 A.60012014 BDSX O.00638181 O.01951358 O.04749349 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++BIODESIX+INC+++++++++++++++++++++++++++Filed+by%3A+Soleus+Capital+Master+Fund%2C+L.P./26462242.html si-local-file:///var/storage/secattach/20260508/26462242.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++BIODESIX+INC+++++++++++++++++++++++++++Filed+by%3A+Soleus+Capital+Master+Fund%2C+L.P./26462242.html Fri, 08 May 2026 17:01:00 -0400 BDSX O.04749349